SweetValueLab
Write for us

Intuitive Surgical, Inc. — Intrinsic Value & Fair Price

ISRG
NASDAQHealthcareMedical - Instruments & SuppliesCIK 0001035267intuitive.comAbout ISRG
Last close · Oct 16, 2026426.70−1.16 (−0.27%)
Market cap$150.7B
Model value · DCF · Perpetuity growth · 5y
138.58
Intuitive Surgical closed at $426.70 — overvalued by 208% vs model.
101.84the model's range229.99

DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
55.31 – 701.72
Wall St. target
434.50 2% below
Above model, 1y
21 of 21 days

Price and model value

Embed this card

ISRG's close against its model value, as a 420×168 card for your own page. It updates nightly with this site and links back here.

Free to embed; keep the attribution link.
Loading chart…
What the marks mean
Daily close

Valuation models

price $426.70 · as of Oct 17, 2026

DCF · Perpetuity growth · 5y leads for a high-growth company — positive operating income and three years of positive free cash flow. How we value a stock walks through every input. The price is 208% above the model value: the models see only the filed business, and a company priced on businesses with no revenue line yet is better taken apart, as Tesla is.

engine pkg:0.1.0

Research on ISRG

No posts on ISRG yet.
Studied ISRG from its filings? Guest posts are reviewed before they go live.Write about ISRG →

How it is valued

Valued asHigh growth
Moderate growth (~19% recent)High profitability (28% net margin)Moderately volatile earnings
What growth the price implies: the reverse DCF

Key figures

FY2025 · chosen for high-growth companies
Price / sales
15.1×
Revenue growth
20.5%
Gross margin
66.0%
Operating margin
29.3%
FCF margin
24.7%
EV / EBITDA
37.0×
Full financials

Analyst actions

third-party, quoted
10-13Mizuho Securities · target415.00
10-12BTIG · target454.00
10-06Barclays · target485.00
08-12Oppenheimer · “Outperform” from “Perform”upgrade
Ratings, targets and estimates

The weekly

One email a week across every stock we cover: 13F filings, insider trades, earnings and new research. It covers the whole market, not just ISRG. No account.

About Intuitive Surgical

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

CEO
David J. Rosa
Headquarters
Sunnyvale, CA
Employees
17,021
IPO
2000-06-16
Full company profile

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; the formulas are in how we value a stock.